Suspected Ocular Toxoplasmosis in Patients with ABCA4-Related Maculopathy - Summary - MDSpire

Suspected Ocular Toxoplasmosis in Patients with ABCA4-Related Maculopathy

  • By

  • Maram E. A. Abdalla Elsayed

  • Vincenzo Barone

  • Robert E. MacLaren

  • January 6, 2026

  • 0 min

Share

Objective:

To present a case of a young adult male with suspected ocular toxoplasmosis, which was ultimately ruled out, leading to a diagnosis of ABCA4-associated macular dystrophy.

Key Findings:
  • The patient exhibited bilateral macular excavation resembling colobomas, which is significant for differential diagnosis.
  • Serological tests were negative for Toxoplasma gondii and other infections, supporting the diagnosis of ABCA4-associated macular dystrophy.
  • Electrophysiological tests indicated retinal dysfunction consistent with ABCA4-associated macular dystrophy, confirming the diagnosis.
Interpretation:

The initial suspicion of ocular toxoplasmosis was ruled out through comprehensive testing, highlighting the importance of accurate differential diagnosis in similar cases.

Limitations:
  • The study is based on a single case report, limiting generalizability to broader populations.
  • Retrospective data collection may introduce bias, affecting the reliability of the findings.
Conclusion:

This case highlights the importance of thorough diagnostic evaluation in distinguishing between ocular toxoplasmosis and inherited retinal diseases like ABCA4-associated maculopathy, emphasizing the need for careful clinical assessment.

Original Source(s)

Suspected Ocular Toxoplasmosis in Patients with ABCA4-Related Maculopathy

  • by Maram E. A. Abdalla Elsayed, Vincenzo Barone, Robert E. MacLaren

  • January 6, 2026

Related Content

Atsena Reports LIGHTHOUSE data at ARVO

Atsena Therapeutics announced positive clinical data results from Part A of the LIGHTHOUSE study, a phase 1/2 clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS). The data were presented at the 2025 Association for Research in Vision and Ophthalmology meeting in Salt Lake City, Utah.

  • May 1, 2025

  • 3 min
Trends and Key Areas of Research in the Pathophysiology, Imaging, and Treatment of Type 3 Macular Neovascularization (MNV3) Associated with Age-Related Macular Degeneration (AMD)

Racing Toward Efficient AI Workflows

At the Focus A-Eye Summit, in the session “Lessons from Formula One: Optimizing Clinical Workflow with AI,” experts examined how artificial intelligence can streamline and accelerate ophthalmic clinical workflows.